Загрузка...
Clinicopathologic Features of Breast Cancer Reclassified as HER2-Amplified by Fluorescence In Situ Hybridization with Alternative Chromosome 17 Probes
OBJECTIVE: Dual probe fluorescence in situ hybridization (FISH) assays for determination of human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer provide a ratio of HER2 to chromosome 17. The ratio may be skewed by copy number alterations (CNA) in the control locus for...
Сохранить в:
| Опубликовано в: : | Ann Diagn Pathol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907993/ https://ncbi.nlm.nih.gov/pubmed/32805517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.anndiagpath.2020.151576 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|